HIGHLIGHTS
- who: Min Tang-Fichaux et al. from the Service de Bactu00e9riology-Hygiu00e8ne, Hu00f4pital Purpan, CHU de Toulouse, Toulouse, France have published the Article: Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?, in the Journal: Toxins 2021, 897 of /2021/
- what: The authors focus on discussing the pro-tumorigenic interplay between inflammation and pks+ E. coli.
- how: The results are consistent with an earlier report which shows that mesalamine inhibits the transcription of pks genes and reduces DSBs caused by pks+ E. coli .
- future: Still . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.